e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical management of lung transplant recipients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tacrolimus versus cyclosporine for lung transplant recipients in Portugal
D. Tavares Teixeira Da Silva (Lisbon, Portugal), C. Dantas (Lisbon, Portugal), M. Emiliano (Lisbon, Portugal), L. Semedo (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal)
Source:
Virtual Congress 2020 – Clinical management of lung transplant recipients
Session:
Clinical management of lung transplant recipients
Session type:
E-poster session
Number:
1937
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. Tavares Teixeira Da Silva (Lisbon, Portugal), C. Dantas (Lisbon, Portugal), M. Emiliano (Lisbon, Portugal), L. Semedo (Lisbon, Portugal), J. Cardoso (Lisbon, Portugal). Tacrolimus versus cyclosporine for lung transplant recipients in Portugal. 1937
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Comparison of post renal transplant tuberculosis cases receiving conventional immunosupressive therapy and mycophenolat mofetil (MMF) and/or tacrolimus (TAC)
Source: Eur Respir J 2003; 22: Suppl. 45, 157s
Year: 2003
Aerosolized liposomal cyclosporine A for treatment of progressive allograft dysfunction following lung transplantation
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013
Long-term kinetics of CD19+CD24highCD38highBreg cells in lung transplant recipients
Source: International Congress 2016 – Lung allograft dysfunction: insights into inflammatory/immune mechanisms
Year: 2016
Early sirolimus immunosuppression is safe in lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012
Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans
Source: Eur Respir J 2004; 23: 384-390
Year: 2004
Airway cellular response to two different immunosuppressive regimens in lung transplant recipients
Source: Eur Respir J 2004; 24: Suppl. 48, 466s
Year: 2004
Results of switch from mycophenolate mofetil to azathioprin after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 178s
Year: 2004
Mycophenolate mofetil (MMF) rescue therapy in lung transplantation: results and pharmacokinetics
Source: Eur Respir J 2002; 20: Suppl. 38, 348s
Year: 2002
Evaluation of the biological effects of atorvastatin in lung transplant recipients
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
Pulmonary alveolar proteinosis due to mycophenolate and cyclosporine combination therapy in a renal transplant recipient
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Hepatic veno-occlusive disease due to tacrolimus in a single-lung transplant patient
Source: Eur Respir J 2006; 27: 1066-1068
Year: 2006
Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation
Source: Eur Respir J 2016; 48: 1807-1810
Year: 2016
Metapneumovirus pneumonia in allogeneic stemcell transplant recipients
Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections
Year: 2011
Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 298s
Year: 2001
CMV management in lung transplant recipients
Source: School Course 2012 - Lung Transplantation
Year: 2012
Azithromycin (Azi) treatment for chronic allograft dysfunction after lung transplantation (LTx)
Source: Annual Congress 2003 - Bronchiolitis obliterans: diagnosis and treatment
Year: 2003
Evaluation of early conversion to prolonged-release tacrolimus in lung transplantation.
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Curcumin in combination with low-dose cyclosporine a in experimental airway transplantation
Source: Eur Respir J 2007; 30: Suppl. 51, 518s
Year: 2007
Association between tacrolimus levels in the first fifteen days post lung transplant and rejection during the first year
Source: International Congress 2016 – Long-term outcomes of lung transplantation
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept